Fluxion New Products Posted to GenomeWeb: Horizon Discovery, Fluxion Biosciences, Caris Life Sciences, More Fluxion Bio Wins $280K NIH Grant to Develop NIPT Assay The firm will validate a model system for test development, integrate key test components, and compare Spotlight to other NIPT assays. Fluxion Biosciences, Cleveland Clinic Validating Erase-Seq Mutation Variant Caller Platform Premium The firm is partnering with the Cleveland Clinic to validate its mutation variant caller platform in hepatocellular cancer cell-free tumor DNA samples. Fluxion, Harvard Bioscience Ink Distribution Deal Harvard Bioscience will offer Fluxion's BioFlux and IonFlux cellular analysis platforms to its North American customers. Fluxion Bioscience, UTHealth Collaborate on Liquid Biopsy Development Both institutions aim to develop novel liquid biopsy approaches that would improve physicians' ability to diagnose, monitor, and treat cancer patients. Jun 2, 2015 Swift Bio, Fluxion Develop Liquid Biopsy Workflow Jun 18, 2014 Fluxion, Stanford Team on CTC Test Development Jul 30, 2013 Bulldog Bio, Fluxion Reach Distribution Deal for Flow Cell Instruments May 28, 2013 Molecular Devices Inks Distribution Deal with Fluxion Biosciences Oct 15, 2012 Fluxion Registers Facility with FDA for Manufacture of IsoFlux System Oct 12, 2012 Cellectricon, Fluxion Settle Microfluidic Cellular Analysis IP Dispute Jun 28, 2012 Fluxion, Stanford Co-Developing Tests for CTCs Jun 5, 2012 Fluxion, Rubicon Team on CTC Applications Jun 1, 2012 In Brief This Week: Transgenomic; Fluxion Biosciences; Silicon Biosystems; DNA Genotek; Annai Systems Feb 3, 2010 Fluxion Denies IP Infringement Claims Made by Cellectricon Dec 4, 2009 Fluxion Biosciences Expands into Asian Market Aug 20, 2009 Fluxion Nets $1.8M NIH Grant Jul 23, 2009 Fluxion Nets $200K SBIR Grant Apr 22, 2009 Fluxion Taps EuroClone as Distributor Feb 27, 2009 New Products: Feb 27, 2009 Premium Breaking News GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.